CLOSE X

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE4596.20-18.15 (-0.39 %)
PREV CLOSE ( ) 4614.35
OPEN PRICE ( ) 4596.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 185
TODAY'S LOW / HIGH ( )4545.05 4636.05
52 WK LOW / HIGH ( )4360.3 5954
NSE4617.2013.5 (+0.29 %)
PREV CLOSE( ) 4603.70
OPEN PRICE ( ) 4597.30
BID PRICE (QTY) 4617.20 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4617
TODAY'S LOW / HIGH( ) 4551.00 4632.00
52 WK LOW / HIGH ( )4537.45 5894.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 10-05 2023
Management Info
Amit Jain - Chairman Himanshu Bakshi - Managing Director
Registered Office

Address Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 45288855

Email igrc.schil@sanofi.com

Website www.sanofi.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
10Oct Sanofi Consumer Healthcare India inf
In accordance with Regulation 30 of the SEBI (Listing Obligations and Di..
05Aug Sanofi Consumer Healthcare India repor
Sanofi Consumer Healthcare India has reported result for second quarter..
05Aug Sanofi Consumer Healthcare India zooms
Sanofi Consumer Healthcare India is currently trading at Rs. 5319.55, up..
13Jun Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that the exchange has rece..
11Apr Sanofi Consumer Healthcare India infor
Pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Sha..
Financials
in Millions
QTR Sep 25 ANNUAL 24
Net Profit6291810
Gross Profit 841 2468
Operating Profit 8802836
Net Sales 23397245
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
up  1128.80 (6.39%)
M.Cap ( in Cr)777.96
Amrutanjan Healthcar (BSE)
up  689.65 (6.38%)
M.Cap ( in Cr)1993.82
Lupin (BSE)
up  2114.10 (1.62%)
M.Cap ( in Cr)96571.84
Panacea Biotec (BSE)
up  362.70 (9.53%)
M.Cap ( in Cr)2221.56
Emcure Pharma (BSE)
up  1439.60 (2.18%)
M.Cap ( in Cr)27289.76
Shareholding Pattern
PROMOTERS 71.27%
MUTUAL FUNDS/UTI 13.34%
NON-INSTITUTION 8.58%
FI/BANKS/INSURANCE 3.87%
FII 0.01%
GOVERNMENT 0%
Mf Holdings
Scheme NameHold(%)
Bajaj Finserv Healthcare Fund-Reg(G)2.17
Sundaram Small Cap Fund(G)1.92
Bajaj Finserv Balanced Advantage Fund-Reg(G)1.59
Nippon India Pharma Fund(G)1.42
ICICI Pru Smallcap Fund(G)1.33
Aditya Birla SL Small Cap Fund(G)1.28
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)1.27
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors